Medical News

RSS

AOD Software named to 2010 Inc. 5000 list of fastest-growing private companies

Inc. magazine ranked AOD Software on its annual Inc. 5000, an exclusive ranking of the nation's fastest-growing private companies. The list represents the most comprehensive look at the most important segment of the economy — America's independent-minded entrepreneurs. AOD Software was ranked as number 219 across the Software companies in the country.

31 Aug 2010

FDA grants Priority Review status to Alimera Sciences' Iluvien for diabetic macular edema

Alimera Sciences, Inc.,, a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that the Company's New Drug Application (NDA) for Iluvien® (fluocinolone acetonide intravitreal insert) has been accepted for filing and granted Priority Review status by the U.S. Food and Drug Administration (FDA).

31 Aug 2010

VA's liabilities grow as agency expands list of diseases linked to Agent Orange

Politico looks at a new fight brewing over Agent Orange and how it affects programs for Vietnam Veterans. "It's a world turned upside-down from decades ago when returning soldiers had to fight to get attention for deadly lymphomas linked to the herbicide. Now the frailties of men in their 60s — prostate cancer, diabetes, heart disease — lead the list of qualified Agent Orange disabilities, and the result has been an explosion in claims — and the government's liability.

31 Aug 2010

FDA extends Prescription Drug User Fee Act date for ezogabine

GlaxoSmithKline and Valeant Pharmaceuticals International announced today the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for ezogabine to 30 November 2010.

31 Aug 2010

Intendis granted rights to KYTHERA's ATX-101 candidate for minimally-invasive fat reduction outside US, Canada

KYTHERA Biopharmaceuticals, Inc. and Intendis, Bayer HealthCare's dermatology business, today announced that they have entered into a licensing agreement granting Intendis rights to KYTHERA's lead product candidate, ATX-101, outside of the US and Canada. ATX-101, a first-in-class investigational drug, is currently in clinical development for the reduction of localized fat under the chin (submental fat).

31 Aug 2010

Medicare beneficiaries receive prescription drug cost relief under Affordable Care Act

U.S. Department of Health and Human Services Secretary Kathleen Sebelius today announced that more than 1 million Medicare beneficiaries have received prescription drug cost relief through the Affordable Care Act.

31 Aug 2010

Elan Corporation offers to purchase Senior Fixed Rate Notes due 2013

Elan Corporation, plc announced today that Elan's wholly-owned subsidiaries, Elan Finance public limited company and Elan Finance Corp., commenced an offer to purchase of up to $186,000,000 aggregate principal amount of their 8 7/8% Senior Fixed Rate Notes due 2013 (the "2013 Fixed Rate Notes") and their Floating Rate Notes Due 2013 (the "2013 Floating Rate Notes" together with the 2013 Fixed Rate Notes, the "2013 Notes"),

31 Aug 2010

Bionovo announces reverse stock split to maintain NASDAQ Capital Market common stock

Bionovo, Inc. announced today that it will effect a 1-for-5 reverse stock split, that will become effective with the opening of trading on August 31, 2010.

31 Aug 2010

Unilife Corporation 2010 fourth quarter revenue increases to $2.7 million

Unilife Corporation today announced preliminary financial results for the fourth quarter and fiscal year ended June 30, 2010.

31 Aug 2010

Origin Agritech 2010 third quarter revenue decreases to $68.07 million

Origin Agritech Limited, a technology focused supplier of crop seeds in China, today announced unaudited financial results for the third quarter ended June 30, 2010. Origin prepares its financial statements in accordance with generally accepted accounting principles (GAAP) of the United States.

31 Aug 2010

Many public hospitals face increasingly pressures; Nonprofit hospitals face uncertain futures

The Wall Street Journal: "Faced with mounting debt and looming costs from the new federal health-care law, many local governments are leaving the hospital business, shedding public facilities that can be the caregiver of last resort. … More than a fifth of the nation's 5,000 hospitals are owned by governments and many are drowning in debt caused by rising health-care costs, a spike in uninsured patients, cuts in Medicare and Medicaid and payments on construction bonds sold in fatter times.

30 Aug 2010

Canada should publicly fund smoking cessation pharmacotherapies: CMAJ

Canada should follow the lead of Quebec, Australia and the United Kingdom by publicly funding smoking cessation pharmacotherapies, states an editorial in CMAJ http://www.cmaj.ca/embargo/cmaj101140.pdf.

30 Aug 2010

Study: Explosion of medical imaging due partly to overuse

"Part of the explosion in medical imaging over the past two decades may be attributable to overuse, and steps need to be taken to cut back," according to a study in the journal Radiology, MedPage Today/ABC News reports.

30 Aug 2010

$Heparin enoxaparin may provide better outcomes than unfractionated heparin$

Heparin enoxaparin may provide better outcomes than unfractionated heparin

Results from ATOLL, a phase 3 randomised trial comparing two anticoagulants in primary PCI for ST elevation MI, show that the low molecular weight heparin enoxaparin may provide better outcomes in such cases than the traditionally used unfractionated heparin.

30 Aug 2010

St. Mary's Medical Center to implement ProVation Order Sets customizable authoring and management solution

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that St. Mary's Medical Center has selected ProVation® Order Sets, powered by UpToDate® Decision Support, as the organization's electronic order set solution.

30 Aug 2010

U.N.-NGO conference on MDGs kicks off in Australia

Ahead of next month's U.N. Summit in New York, a joint U.N.-NGO conference tracking the world's progress toward reaching the U.N. Millennium Development Goals (MDGs) kicked off in Melbourne, Australia, on Monday, ABC News reports (8/30).

30 Aug 2010

Greater Sacramento Specialty Pharmacy acquired by The Apothecary Shops

The Apothecary Shops, a Phoenix-based chain of specialty pharmacies with 16 locations in six states, has acquired the Greater Sacramento Specialty Pharmacy (GSP), a customer-service focused pharmacy with primary specialties in oncology and pain management.

30 Aug 2010

Phase 2 INNOVATE PCI trial results for elinogrel presented

Phase 2 trial results for elinogrel, a novel antiplatelet agent available in both intravenous and oral formulations, were presented here today.

30 Aug 2010

Record number taking anti-poverty programs, COBRA coverage alternatives examined

One in six Americans is now taking advantage of government anti-poverty programs, including more than 50 million on Medicaid, for which enrollment is up 17 percent since the recession began in December 2007, USA Today reports. "The program has grown even before the new health care law adds about 16 million people, beginning in 2014. That has strained doctors. … As caseloads for all the programs have soared, so have costs. The federal price tag for Medicaid has jumped 36% in two years, to $273 billion. Jobless benefits have soared from $43 billion to $160 billion.

30 Aug 2010

H. D. Smith becomes primary supplier of pharmaceutical products for NAPPSA pharmacies

NAPPSA, a pharmacy buying group advancing the growing buying power of the Nigerian-owned independent retailers, today announced a new three-year prime vendor agreement with H. D. Smith, a leading national pharmaceutical wholesaler.

30 Aug 2010

Medical News

AOD Software named to 2010 Inc. 5000 list of fastest-growing private companies

FDA grants Priority Review status to Alimera Sciences' Iluvien for diabetic macular edema

VA's liabilities grow as agency expands list of diseases linked to Agent Orange

FDA extends Prescription Drug User Fee Act date for ezogabine

Intendis granted rights to KYTHERA's ATX-101 candidate for minimally-invasive fat reduction outside US, Canada

Medicare beneficiaries receive prescription drug cost relief under Affordable Care Act

Elan Corporation offers to purchase Senior Fixed Rate Notes due 2013

Bionovo announces reverse stock split to maintain NASDAQ Capital Market common stock

Unilife Corporation 2010 fourth quarter revenue increases to $2.7 million

Origin Agritech 2010 third quarter revenue decreases to $68.07 million

Many public hospitals face increasingly pressures; Nonprofit hospitals face uncertain futures

Canada should publicly fund smoking cessation pharmacotherapies: CMAJ

Study: Explosion of medical imaging due partly to overuse

Heparin enoxaparin may provide better outcomes than unfractionated heparin

St. Mary's Medical Center to implement ProVation Order Sets customizable authoring and management solution

U.N.-NGO conference on MDGs kicks off in Australia

Greater Sacramento Specialty Pharmacy acquired by The Apothecary Shops

Phase 2 INNOVATE PCI trial results for elinogrel presented

Record number taking anti-poverty programs, COBRA coverage alternatives examined

H. D. Smith becomes primary supplier of pharmaceutical products for NAPPSA pharmacies

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Latest News